4506 Sumitomo Pharma Co.,Ltd.住友ファーマTSE Prime / Pharmaceuticals
0 posts
Sumitomo Pharma Co.,Ltd. (4506) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Sumitomo Pharma Co.,Ltd. (4506) Stock Price History
Sumitomo Pharma Co.,Ltd. closed at ¥1,820 on Nov 20, 2026, −3.5% over 1 month, −32.7% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥96,474 today (−3.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −3.5%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥1,820 | −76 | −4.01% |
| Nov 19 (Thu) | ¥1,896 | +2 | +0.11% |
| Nov 18 (Wed) | ¥1,894 | −76.5 | −3.88% |
| Nov 17 (Tue) | ¥1,970 | −48 | −2.38% |
| Nov 16 (Mon) | ¥2,018 | −10 | −0.49% |
| Nov 13 (Fri) | ¥2,028 | +54.5 | +2.76% |
| Nov 12 (Thu) | ¥1,974 | +39.5 | +2.04% |
| Nov 11 (Wed) | ¥1,934 | −4.5 | −0.23% |
| Nov 10 (Tue) | ¥1,939 | +24 | +1.25% |
| Nov 9 (Mon) | ¥1,915 | +76.5 | +4.16% |
If you had invested ¥100,000 3 months ago, it would be worth ¥124,198 today (+24.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved +24.2%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥1,820 | −76 | −4.01% |
| Nov 19 (Thu) | ¥1,896 | +2 | +0.11% |
| Nov 18 (Wed) | ¥1,894 | −76.5 | −3.88% |
| Nov 17 (Tue) | ¥1,970 | −48 | −2.38% |
| Nov 16 (Mon) | ¥2,018 | −10 | −0.49% |
| Nov 13 (Fri) | ¥2,028 | +54.5 | +2.76% |
| Nov 12 (Thu) | ¥1,974 | +39.5 | +2.04% |
| Nov 11 (Wed) | ¥1,934 | −4.5 | −0.23% |
| Nov 10 (Tue) | ¥1,939 | +24 | +1.25% |
| Nov 9 (Mon) | ¥1,915 | +76.5 | +4.16% |
If you had invested ¥100,000 6 months ago, it would be worth ¥119,704 today (+19.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved +19.7%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥1,820 | −3.4% |
| Oct 2026 | ¥1,885 | +15.9% |
| Sep 2026 | ¥1,627 | +4.7% |
| Aug 2026 | ¥1,554 | +24.5% |
| Jul 2026 | ¥1,248 | −16.9% |
| Jun 2026 | ¥1,501 | −7.5% |
| May 2026 | ¥1,623 | −5.6% |
If you had invested ¥100,000 1 year ago, it would be worth ¥67,339 today (−32.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −32.7%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥1,820 | −3.4% |
| Oct 2026 | ¥1,885 | +15.9% |
| Sep 2026 | ¥1,627 | +4.7% |
| Aug 2026 | ¥1,554 | +24.5% |
| Jul 2026 | ¥1,248 | −16.9% |
| Jun 2026 | ¥1,501 | −7.5% |
| May 2026 | ¥1,623 | −5.6% |
| Apr 2026 | ¥1,720 | −17.2% |
| Mar 2026 | ¥2,076 | −17.8% |
| Feb 2026 | ¥2,524 | +9.9% |
| Jan 2026 | ¥2,297 | −0.9% |
| Dec 2025 | ¥2,318 | −15.1% |
| Nov 2025 | ¥2,730 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥368,320 today (+268.3%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved +268.3%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥1,820 | −21.5% |
| 2025 | ¥2,318 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥126,794 today (+26.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved +26.8%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥1,820 | −21.5% |
| 2025 | ¥2,318 | ― |
If you had invested ¥100,000 in Feb 2000, it would be worth ¥212,807 today (+112.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +177.5%, while this stock moved +112.8%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥1,820 | −21.5% |
| 2025 | ¥2,318 | +311.7% |
| 2024 | ¥563 | +20.8% |
| 2023 | ¥466 | −53.4% |
| 2022 | ¥999 | −24.6% |
| 2021 | ¥1,325 | −13.0% |
| 2020 | ¥1,523 | −28.5% |
| 2019 | ¥2,130 | −39.1% |
| 2018 | ¥3,495 | +108.8% |
| 2017 | ¥1,674 | −16.7% |
| 2016 | ¥2,010 | +40.5% |
| 2015 | ¥1,431 | +22.2% |
| 2014 | ¥1,171 | −28.8% |
| 2013 | ¥1,645 | +58.9% |
| 2012 | ¥1,035 | +18.0% |
| 2011 | ¥877 | +18.8% |
| 2010 | ¥738 | −24.4% |
| 2009 | ¥976 | +17.3% |
| 2008 | ¥832 | +1.7% |
| 2007 | ¥818 | −40.9% |
| 2006 | ¥1,384 | +25.2% |
| 2005 | ¥1,105 | +7.2% |
| 2004 | ¥1,031 | +40.3% |
| 2003 | ¥735 | −25.9% |
| 2002 | ¥992 | −25.4% |
| 2001 | ¥1,330 | −29.6% |
| 2000 | ¥1,890 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Feb 2000). Please check the latest prices before trading.
Sumitomo Pharma Co.,Ltd. (4506) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of Sumitomo Pharma Co.,Ltd. (4506)
Business overview
The company is a pharmaceutical maker that manufactures, purchases and sells prescription drugs, and its parent is Sumitomo Chemical. It makes and sells prescription drugs in Japan and North America, and through joint ventures with Sumitomo Chemical it provides contract process development and manufacturing for regenerative and cell medicine and researches regenerative medicine products. In Asia, a joint venture with Marubeni Global Pharma handles prescription drugs.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| Dividend yield | 0.82% | No. 37 in the sector (highest first); median 2.97% |
|---|---|---|
| PER | 8.6x | Below the sector median of 16.5x (No. 3 from the lowest) |
| PBR | 1.89x | Above the sector median of 1.86x (No. 40 from the lowest) |
| ROE | 21.96% | No. 1 in the sector (highest first); median 4.17% |
| Market cap | ¥816.2 bn | No. 10 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥3,184 | 2/17 |
|---|---|---|
| 52-week low | ¥1,230 | 8/4 |
| Current position | 30.2% | Where the low is 0% and the high is 100% (close on 11/20: ¥1,820) |
| Year to date | -21.5% | No. 46 of 77 in the sector (best first) |
| 1 year | -32.7% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 1 times | Latest: 10/15 (No. 9) |
|---|
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 10/30 15:302027年3月期第2四半期(中間期)決算短信〔IFRS〕(連結)
- 10/30 15:302027年3月期第2四半期(中間期)連結業績予想と実績との差異および通期連結業績予想の修正に関するお知らせ
- 10/30 15:302027年3月期期末配当予想の修正に関するお知らせ
- 10/30 15:302026年度(2027年3月期)第2四半期決算 決算説明会資料
- 10/30 15:302026年度(2027年3月期)第2四半期決算(IFRS)補足資料
Filings from the past 12 months (5).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the Sumitomo Pharma Co.,Ltd. board
More Japanese stocks in English
- Shionogi & Co.,Ltd.4507
- State Street SPDR S&P 500 ETF (JPY Hedged)450A
- WAKAMOTO PHARMACEUTICAL CO.,LTD.4512
- Nippon Shinyaku Co.,Ltd.4516
- State Street SPDR S&P 500 High Dividend ETF (JPY Unhedged)451A
- KAKEN PHARMACEUTICAL CO.,LTD.4521
- MORISHITA JINTAN CO.,LTD.4524
- RIKEN VITAMIN CO.,LTD.4526
- ROHTO PHARMACEUTICAL CO.,LTD.4527
- ONO PHARMACEUTICAL CO.,LTD.4528
- iShares S&P 500 Premium Income ETF452A
- Yuki Gosei Kogyo Co.,Ltd.4531